Skip to main content

Dr. Raetz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Raetz's full profile

Already have an account?

  • Office

    160 E 32nd St
    2nd Floor
    New York, NY 10016
    Phone+1 212-263-9918

Education & Training

  • University of Utah Health
    University of Utah HealthFellowship, Pediatric Hematology/Oncology, 1995 - 1998
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Pediatrics, 1992 - 1995
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1992

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2002 - 2025
  • UT State Medical License
    UT State Medical License 1995 - 2020
  • MT State Medical License
    MT State Medical License 2017 - 2019
  • WI State Medical License
    WI State Medical License 1994 - 1995
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Inotuzumab Ozogamicin in Pediatric Patients with relapsed/refractory Acute Lymphoblastic Leukemia  
    Deepa Bhojwani, Constance Yuan, Jennifer L McNeer, Mignon L Loh, Vilmarie Rodriguez, Susan R Rheingold, Elizabeth A Raetz, Nature
  • Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group  
    Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood

Abstracts/Posters

  • Identification of New Risk Loci and Regulatory Mechanisms Influencing Genetic Susceptibility to Acute Lymphoblastic Leukaemia
    Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient ...
    Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...
    Elizabeth A. Raetz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Induction Toxicities Are More Frequent in Young Adults Compared to Children Treated on the Children's Oncology Group (COG) First Relapse B-Lymphoblastic Leukemia Clini... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Seattle Children’s Researchers Greatly Improve Survival for Children Diagnosed with the Most Common Form of Childhood Cancer, Changing the Standard of Care
    Seattle Children’s Researchers Greatly Improve Survival for Children Diagnosed with the Most Common Form of Childhood Cancer, Changing the Standard of CareDecember 7th, 2024
  • Pregnant ‘90 Day Fiance’ Star Deavan Clegg, 25, Says Her Son, 3, Has Cancer and Asks for Donations: ‘It’s the Most Vulnerable and Saddest Point of My Life’
    Pregnant ‘90 Day Fiance’ Star Deavan Clegg, 25, Says Her Son, 3, Has Cancer and Asks for Donations: ‘It’s the Most Vulnerable and Saddest Point of My Life’June 1st, 2022
  • Incorporating Immunotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia
    Incorporating Immunotherapy for Relapsed Pediatric Acute Lymphoblastic LeukemiaAugust 13th, 2020
  • Join now to see all